Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 12/2011

Content (13 Articles)

Original article

Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function

Ardiana Moustaki, Kimon V. Argyropoulos, Constantin N. Baxevanis, Michael Papamichail, Sonia A. Perez

Original Article

Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia

Yoon Kyung Jeon, Hye Sook Min, Yoo Jeong Lee, Byung Hyun Kang, Eun Ji Kim, Hyo Jin Park, Youngmee Bae, Hyun Gyu Lee, Weon Seo Park, Hyung Geun Song, Kyeong Cheon Jung, Seong Hoe Park

Original article

Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients

Kei Suzuki, Kyuichi Kadota, Camelia S. Sima, Michel Sadelain, Valerie W. Rusch, William D. Travis, Prasad S. Adusumilli

Original article

Prognostic impact of B-cell density in cutaneous melanoma

Andrea Ladányi, Judit Kiss, Anita Mohos, Beáta Somlai, Gabriella Liszkay, Katalin Gilde, Zsuzsanna Fejős, István Gaudi, Judit Dobos, József Tímár

Original article

A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment

Gabriele Cantini, Federica Pisati, Alfonso Mastropietro, Véronique Frattini, Yoichiro Iwakura, Gaetano Finocchiaro, Serena Pellegatta

Original article

Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity

Xiaoli Yan, Xiaojun Zhang, Yanzhong Wang, Xinghui Li, Saifeng Wang, Bao Zhao, Yang Li, Ying Ju, Lizhao Chen, Wenjun Liu, Songdong Meng

Original article

Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses

Shannon E. Smith, Dominique B. Hoelzinger, Ana Lucia Dominguez, Jacques Van Snick, Joseph Lustgarten

Original article

Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface

Jennifer A. A. Gubbels, Brian Gadbaw, Ilia N. Buhtoiarov, Sachi Horibata, Arvinder K. Kapur, Dhara Patel, Jacquelyn A. Hank, Stephen D. Gillies, Paul M. Sondel, Manish S. Patankar, Joseph Connor

Original article

H2O2 production within tumor microenvironment inversely correlated with infiltration of CD56dim NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction

Shinichirou Izawa, Koji Kono, Kousaku Mimura, Yoshihiko Kawaguchi, Mitsuaki Watanabe, Takanori Maruyama, Hideki Fujii

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine